Key result
Following cavo-tricuspid isthmus ablation, recurrent AF occurred in 27% of patients with prior atrial flutter alone compared to 61% of those with both prior atrial flutter and AF.
Why the study?
Does cavo-tricuspid isthmus ablation prevent atrial fibrillation recurrence in patients with atrial flutter alone versus those with combined atrial flutter and atrial fibrillation?
Cohort (n=141)
Does cavo-tricuspid isthmus ablation prevent atrial fibrillation recurrence in patients with atrial flutter alone versus those with combined atrial flutter and atrial fibrillation?
Cavo-tricuspid isthmus ablation is curative in over 70% of patients with isolated atrial flutter, but frequently fails to prevent AF in patients with a history of both arrhythmias.
Answers are grounded in this paper and cite their sources.
CTI ablation may cure isolated flutter long-term; leaves open AF prevention when flutter coexists with documented AF.
OBJECTIVE: Both atrial flutter and atrial fibrillation (AF) frequently develop in the same patient. There is therefore reasonable doubt that flutter ablation may not solve the clinical problem, owing to the occurrence/recurrence of AF. The aim of this study was to establish whether cavo-tricuspid isthmus ablation is curative in patients with common atrial flutter alone or combined with AF. METHODS: One hundred and forty-one patients (114 male, 27 female, mean age 63 +/- 10 years) who had cavo-tricuspid isthmus ablation were followed up for 44 +/- 20 months. Before ablation, 48 patients had only atrial flutter (group A), whereas 93 patients had both atrial flutter and AF. Among the latter, during antiarrhythmic therapy, 31 patients had only atrial flutter (group B1), whereas 62 patients (group B2) continued to experience both arrhythmias. RESULTS: During follow-up, 27% of group A and 61% of group B patients had documented recurrent AF (P < 0.001). AF recurred in 51% of group B1 and in 66% of group B2 patients (P = NS). Permanent AF occurred in 6% of group A, 3% of group B1 and 21% of group B2 (P < 0.01). Specific symptom scale scores significantly decreased in all groups, particularly in group A. Two patients of group B had cerebral ischaemic attacks. CONCLUSIONS: Over a long-term follow-up, cavo-tricuspid isthmus ablation is curative in >70% of patients with atrial flutter alone. Therefore, if no AF is documented, more extensive ablation is not needed. By contrast, cavo-tricuspid isthmus ablation is frequently unable to prevent AF in patients with both atrial flutter and AF, although in some cases a significant clinical benefit may be obtained.
No takes yet. Share an insight, caveat, or question.
Delise et al. (2006) conducted a cohort in Atrial flutter alone or combined with atrial fibrillation (n=141). Atrial flutter alone prior to ablation vs. Atrial flutter and AF prior to ablation was evaluated on Documented recurrent AF (p=< 0.001). Following cavo-tricuspid isthmus ablation, recurrent AF occurred in 27% of patients with prior atrial flutter alone compared to 61% of those with both prior atrial flutter and AF.
Synapse has enriched 10 related papers. Consider them for comparative context: